Centogene NV (Centogene NV) EV-to-EBIT : -2.88 (As of May. 04, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Centogene NV's Enterprise Value is $61.13 Mil. Centogene NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-21.23 Mil. Therefore, Centogene NV's EV-to-EBIT for today is -2.88.

The historical rank and industry rank for Centogene NV's EV-to-EBIT or its related term are showing as below:

CNTG' s EV-to-EBIT Range Over the Past 10 Years
Min: -19.41 Med: -1.36 Max: -0.4
Current: -2.88

During the past 7 years, the highest EV-to-EBIT of Centogene NV was -0.40. The lowest was -19.41. And the median was -1.36.

CNTG's EV-to-EBIT is ranked worse than
100% of 106 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.805 vs CNTG: -2.88

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Centogene NV's Enterprise Value for the quarter that ended in Jun. 2023 was $91.37 Mil. Centogene NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-21.23 Mil. Centogene NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -23.23%.

Centogene NV EV-to-EBIT Historical Data

The historical data trend for Centogene NV's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV EV-to-EBIT Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-EBIT

Get a 7-Day Free Trial

-9.05

-3.01

-2.01

-1.49

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
EV-to-EBIT	Get a 7-Day Free Trial															-2.01	-1.53	-1.01	-1.49	-

Competitive Comparison of Centogene NV's EV-to-EBIT

For the Diagnostics & Research subindustry, Centogene NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Centogene NV's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Centogene NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Centogene NV's EV-to-EBIT falls into.

Centogene NV EV-to-EBIT Calculation

Centogene NV's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	61.128	/	-21.229
	=	-2.88

Centogene NV's current Enterprise Value is $61.13 Mil.
Centogene NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.23 Mil.

Centogene NV (NAS:CNTG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Centogene NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	-21.229	/	91.36655
	=	-23.23 %

Centogene NV's Enterprise Value for the quarter that ended in Jun. 2023 was $91.37 Mil.
Centogene NV's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.23 Mil.

Centogene NV EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Centogene NV's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV (Centogene NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.